Keywords: Sucampo, Amitiza, Constipation, CIC, UK approval

Sucampo's CIC drug Amitiza gets UK approval

Article | 12 September 2012

Print This

US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received approval from the UK’s Medicines and Healthcare ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in